Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04016376 · ClinicalTrials.gov registry record · Phase 4
Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction
A Phase 4 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,507
- Enrollment target
NCT04016376: Completed Phase 4 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04016376 is a Phase 4 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,507 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04016376, a Phase 4 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,507 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the injection site or sites used for administering pain medication (nerve blocks) before a double mastectomy with immediate reconstruction with tissue expanders reduce the need for pain medication after surgery.
Interventions
- DRUG PVB Protocol
- DRUG PECS-1
- DRUG Serratus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,507 participants |
| Start Date | 2019-07-05 |
| Est. Completion | 2026-02-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04016376
The ClinicalTrials.gov registry entry for NCT04016376 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,507 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PVB Protocol is the first listed.
NCT04016376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04016376 about?
NCT04016376 is a clinical study titled "Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction". The purpose of this study is to determine if the injection site or sites used for administering pain medication (nerve blocks) before a double mastectomy with immediate reconstruction with tissue expanders reduce the need for pain medication after surgery.
What is the current status of trial NCT04016376?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,507 participants. The study started on 2019-07-05. Estimated completion is 2026-02-25.
What interventions are being tested in trial NCT04016376?
The interventions under investigation include: PVB Protocol (DRUG), PECS-1 (DRUG), Serratus (DRUG).
Who is sponsoring clinical trial NCT04016376?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.